Women with PMOS should get subsidised weight loss drugs, advocates say
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.The Polyendrocrine…
This is a short extract from a report by The Guardian. The full text stays with the publisher — follow the link to read it there.
Read at source
